骨髓增生异常综合征转为急性嗜酸粒细胞白血病1例并文献复习  

Acute eosinophilic leukemia transformed from myelodysplastic syndrome:a case report and literature review

作　　者：马金龙[1] 陈宝安[1] 葛峥[1] 丁家华[1] 高冲[1] MA Jinlong;CHEN Bao＇an;GE Zheng;DING Jiahua;GAO Chong(Department of Hematology, Institute of Myelodysplastic Syndrome, Zhongda Hospital, Southeast University, Nanjing 210009, Jiangsu , China)

机构地区：[1]东南大学附属中大医院血液科东南大学骨髓增生异常综合征研究所,南京210009

出　　处：《临床检验杂志》2018年第3期235-238,共4页Chinese Journal of Clinical Laboratory Science

基　　金：国家自然科学基金面上项目(81270613);江苏省医学重点人才项目(RC2011077)

摘　　要：目的观察急性嗜酸粒细胞白血病(AEL)的形态特征、遗传特征、免疫表型及分子标记特征以提高对AEL的认识。方法对我院收治的1例难治性血细胞减少伴多系发育异常(MDS-RCMD)转为AEL患者的病历资料进行回顾性总结并复习相关文献。结果该例MDS-RCMD患者12个月后转为AEL;骨髓原始细胞占10.4%,嗜酸粒细胞占70.8%,其中嗜酸性早、中、晚幼粒细胞占69.6%;外周血嗜酸粒细胞占13.5%;骨髓原始细胞伴有复杂染色体异常、CD34、CD117、HLD-DR、CD33、CD38、CD13等阳性表达;FI1L1/PDGFRα和ETV6/PDGFRα融合基因阴性。按AML治疗2个月后患者死亡。结论该例AEL患者FI1L1/PDGFRα和ETV6/PDGFRα基因重排阴性,伊马替尼治疗无效。Objective To summarize and explore the morphological characteristics,genetic alterations,immunophenotype and characteristics of molecular marker of acute eosinophilic leukemia（ AEL）,and improve the awareness for AEL. Methods A case of refractory hematopoietic dysplasia（ MDS-RCMD） transformed to AEL in our hospital was retrospectively reviewed. Results The MDS-RCMD patient transformed to AEL in 12 months after diagnosis. In his special bone marrow 10. 4% was blasts,while 70. 8% of bone marrow cells were eosinophils including 69. 3% of promyelocyte,myelocyte and metamyelocyte. Eosinophils accounted for 13. 5% in his peripheral blood. The blasts in bone marrow expressed CD34,CD117,HLA-DR,CD33,CD38 and CD13,and accompanied by complex chromosomal abnormalities. FI1 L1/PDGFRα and ETV6/PDGFRβ fusion gene were negative. The patient died two months later following treating with AML regimen. Conclusion The AEL patient with negative FI1 L1/PDGFRα and ETV6/PDGFRβ gene rearrangement,imatinib treatment is ineffectual.

关 键 词：骨髓增生异常综合征 急性嗜酸粒细胞白血病 预后 

分 类 号：R446.11[医药卫生—诊断学] R557[医药卫生—临床医学]